Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nigel Mackman

Showing results (221-230 of 397) with videos related to

Pageof 40
Sort By:
Blood|October 24, 2014
Reduced thrombosis in Klkb1-/- mice is mediated by increased Mas receptor, prostacyclin, Sirt1, and KLF4 and decreased tissue factorEvi X Stavrou, Chao Fang, Alona Merkulova, et al.
Thrombosis and Haemostasis|March 20, 2021
COVID-19 is Associated with an Acquired Factor XIII DeficiencyFien A von Meijenfeldt, Sebastian Havervall, Jelle Adelmeijer, et al.
Journal of Thrombosis and Haemostasis : JTH|October 20, 2019
Effect of blood flow on platelets, leukocytes, and extracellular vesicles in thrombosis of simulated neonatal extracorporeal circulationAndrew D Meyer, Anjana R Rishmawi, Robin Kamucheka, et al.
Blood Advances|December 30, 2022
A novel mouse whole blood thrombin generation assay sensitive to FXI- and FIX-mediated amplification of coagulationJun Wan, Pansakorn Tanratana, Mark Roest, et al.
Blood Advances|December 8, 2022
Thrombin-mediated activation of PAR1 enhances doxorubicin-induced cardiac injury in miceSteven P Grover, Vanthana Bharathi, Jens J Posma, et al.
American Journal of Hematology|January 4, 2021
Elevated factor V activity and antigen levels in patients with Covid-19 are related to disease severity and 30-day mortalityFien A von Meijenfeldt, Sebastian Havervall, Jelle Adelmeijer, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 26, 2018
Response by Daugherty et al to Letter Regarding Article, "Consideration of Sex Differences in Design and Reporting of Experimental Arterial Pathology Studies: A Statement From the <i>Arteriosclerosis, Thrombosis, and Vascular Biology</i> Council"Alan Daugherty, Hong S Lu, Robert A Hegele, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 25, 2018
Roles of Coagulation Proteases and PARs (Protease-Activated Receptors) in Mouse Models of Inflammatory DiseasesJens J Posma, Steven P Grover, Yohei Hisada, et al.
Thrombosis Research|October 27, 2009
Increased microparticle tissue factor activity in cancer patients with Venous ThromboembolismDavid A Manly, Jianguo Wang, Sam L Glover, et al.
Thrombosis Research|March 28, 2024
Mucin 1 and venous thrombosis in tumor-bearing mice and patients with cancerTomohiro Kawano, Cornelia Englisch, Yohei Hisada, et al.
Pageof 40

Showing results (221-230 of 397) with videos related to

Sort By:
Pageof 40
Blood|October 24, 2014
Reduced thrombosis in Klkb1-/- mice is mediated by increased Mas receptor, prostacyclin, Sirt1, and KLF4 and decreased tissue factorEvi X Stavrou, Chao Fang, Alona Merkulova, et al.
Thrombosis and Haemostasis|March 20, 2021
COVID-19 is Associated with an Acquired Factor XIII DeficiencyFien A von Meijenfeldt, Sebastian Havervall, Jelle Adelmeijer, et al.
Journal of Thrombosis and Haemostasis : JTH|October 20, 2019
Effect of blood flow on platelets, leukocytes, and extracellular vesicles in thrombosis of simulated neonatal extracorporeal circulationAndrew D Meyer, Anjana R Rishmawi, Robin Kamucheka, et al.
Blood Advances|December 30, 2022
A novel mouse whole blood thrombin generation assay sensitive to FXI- and FIX-mediated amplification of coagulationJun Wan, Pansakorn Tanratana, Mark Roest, et al.
Blood Advances|December 8, 2022
Thrombin-mediated activation of PAR1 enhances doxorubicin-induced cardiac injury in miceSteven P Grover, Vanthana Bharathi, Jens J Posma, et al.
American Journal of Hematology|January 4, 2021
Elevated factor V activity and antigen levels in patients with Covid-19 are related to disease severity and 30-day mortalityFien A von Meijenfeldt, Sebastian Havervall, Jelle Adelmeijer, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 26, 2018
Response by Daugherty et al to Letter Regarding Article, "Consideration of Sex Differences in Design and Reporting of Experimental Arterial Pathology Studies: A Statement From the <i>Arteriosclerosis, Thrombosis, and Vascular Biology</i> Council"Alan Daugherty, Hong S Lu, Robert A Hegele, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 25, 2018
Roles of Coagulation Proteases and PARs (Protease-Activated Receptors) in Mouse Models of Inflammatory DiseasesJens J Posma, Steven P Grover, Yohei Hisada, et al.
Thrombosis Research|October 27, 2009
Increased microparticle tissue factor activity in cancer patients with Venous ThromboembolismDavid A Manly, Jianguo Wang, Sam L Glover, et al.
Thrombosis Research|March 28, 2024
Mucin 1 and venous thrombosis in tumor-bearing mice and patients with cancerTomohiro Kawano, Cornelia Englisch, Yohei Hisada, et al.
Pageof 40